Autologous mobilized peripheral blood CD34+ cell infusion in non-viral decompensated liver cirrhosis

Table 1 Baseline characteristics between control and study group (mean ± SD)

Parameter	Control group(n = 23)	Study group(n = 22)	P value
Age (yr)	47.35 ± 12.54	48.91 ± 9.25	0.64
Sex ratio (M:F)	20:3	16:6	0.072
Hemoglobin (g/dL)	9.29 ± 1.86	9.15 ± 1.60	0.79
Platelet count (Lakhs/mm3)	0.92 ± 0.27	1.1 ± 0.72	0.24
Total bilirubin (mg/dL)	4.78 ± 4.06	3.55 ± 2.12	0.21
AST (IU/mL)	101.61 ± 174.41	67.14 ± 55.99	0.30
ALT (IU/mL)	77.87 ± 125.54	32.45 ± 17.07	0.10
Albumin (mg/dL)	2.7 ± 0.35	2.55 ± 0.35	0.16
INR	1.72 ± 0.53	1.80 ± 0.52	0.62
Creatinine (mg/dL)	1.08 ± 0.38	1.02 ± 0.29	0.56
MELD score	18.73 ± 5.29	18.28 ± 3.50	0.74

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; IU: International unit; INR: International normalized ratio; MELD: Model for end-stage liver disease score.